Aims: To characterize the pharmacokinetics and metabolism of oral midazolam in 15 preterm infants. Methods: After an oral dose (0.1 mg kg-1), blood was drawn up to 24 h after administration. Midazolam and 1-OH-midazolam concentrations were determined with GC-MS. In 8 out of these 15 patients the pharmacokinetics of intravenous midazolam was also studied. Results: Apparent oral clearance, apparent volume of distribution, plasma half-life and 1-OH-Midazolam/Midazolam AUC ratio were [median (range)]: 2.7 [0.67-15.5] ml kg-1 min-1, 1.4 [0.3-12.1] l kg-1, 7.6 [1.2-15.1], h and 0.03 [0.01-0.96], respectively. Absolute bioavailability was 0.49 [0.12-1.0]. Conclusions: Midazolam oral clearance is markedly decreased in preterm infants as compared with older children, probably because of immature CYP3A4 activity.

, , ,,
British Journal of Clinical Pharmacology
Department of Pediatrics

de Wildt, S., Kearns, G., Hop, W., Murry, D., Abdel-Rahman, S., & van den Anker, J. (2002). Pharmacokinetics and metabolism of oral midazolam in preterm infants. British Journal of Clinical Pharmacology, 53(4), 390–392. doi:10.1046/j.1365-2125.2002.01223.x